abrdn Life Sciences Investors
HQL
54 hedge funds and large institutions have $73.9M invested in abrdn Life Sciences Investors in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 4 reducing their positions, and 4 closing their positions.
575% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 4
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
60% more capital invested
Capital invested by funds: $46.3M → $73.9M (+$27.6M)
23% more funds holding
Funds holding: 44 → 54 (+10)
8.83% more ownership
Funds ownership: 14.47% → 23.3% (+8.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
+$7.68M |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$6.32M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.76M |
| 4 |
NIM
Needham Investment Management
New York
|
+$3.35M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$3.38M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$1.12M |
| 3 |
CFN
Cordasco Financial Network
Naples,
Florida
|
-$779K |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$303K |
| 5 |
TJHA
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
|
-$99.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TFA
51
Transamerica Financial Advisors
St. Petersburg,
Florida
| $1K | – | – | – |
|
|
52
First Trust Advisors
Wheaton,
Illinois
| – | -$1.12M | -51,437 | Closed |
|
|
BA
53
Bard Associates
Chicago,
Illinois
| – | -$303K | -13,933 | Closed |
|
54
US Bancorp
Minneapolis,
Minnesota
| – | -$94K | -4,315 | Closed |
|
|
TDC
55
Thompson Davis & Co
Richmond,
Virginia
| – | -$11K | -509 | Closed |
|
HQL Hedge Fund Activity: Q2 2014 in Review
54 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2014, worth a combined $73.9M — up 60% from $46.3M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new HQL positions and 4 closed out — a net gain of 10 holders — while 27 added to existing stakes and 4 trimmed.
The largest buyer was Sit Investment Associates, adding an estimated $7.68M. The largest seller was Advisors Asset Management, cutting an estimated $3.38M.
- 54 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2014, up from 44 in Q1 2014.
- Funds reported $73.9M of abrdn Life Sciences Investors stock for Q2 2014, up 60% quarter-over-quarter.
- 14 funds opened new abrdn Life Sciences Investors positions in Q2 2014 and 4 closed out, a net change of +10 holders.
- The largest abrdn Life Sciences Investors buyer in Q2 2014 was Sit Investment Associates, an estimated $7.68M added.
- The largest abrdn Life Sciences Investors seller in Q2 2014 was Advisors Asset Management, an estimated $3.38M sold.
Based on aggregated 13F filings for Q2 2014.